Home ›
Trademark Categories ›
Pharmaceuticals ›
2018 ›
SO ›
SOLUXION
Trademark search for:
SOLUXION
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2018-05-25 — Application filed
2018-05-29 — Application filed
2018-06-02 — Application filed
2018-06-05 — Notice of design search code e-mailed
2018-09-05 — Assigned to examiner
2018-09-12 — Final disposition recorded
2018-09-12 — Final disposition recorded
2018-09-12 — Final disposition recorded
2019-03-12 — Office action issued
2019-03-12 — Correspondence received in law office
2019-03-13 — Teas/email correspondence entered
2019-03-14 — Assigned to examiner
2019-03-14 — Approved for pub - principal register
2019-04-03 — Assigned to lie
2019-04-24 — Notification of notice of publication e-mailed
2019-05-14 — Published for opposition
2019-05-14 — Official gazette publication confirmation e-mailed
2019-06-10 — Teas revoke/app/change addr of atty/dom rep received
2019-06-10 — Attorney/dom.rep.revoked and/or appointed
2019-07-09 — Noa e-mailed - sou required from applicant
2019-12-17 — Sou teas extension received
2019-12-17 — Sou extension 1 filed
2019-12-17 — Sou extension 1 granted
2019-12-19 — Notice of approval of extension request e-mailed
2020-06-19 — Sou teas extension received
2020-06-19 — Sou extension 2 filed
2020-06-19 — Sou extension 2 granted
2020-06-23 — Notice of approval of extension request e-mailed
2021-01-06 — Sou teas extension received
2021-01-06 — Sou extension 3 filed
2021-01-06 — Sou extension 3 granted
2021-01-08 — Notice of approval of extension request e-mailed
2021-07-07 — Sou teas extension received
2021-07-07 — Sou extension 4 filed
2021-07-07 — Sou extension 4 granted
2021-07-09 — Notice of approval of extension request e-mailed
2022-02-14 — Application abandoned
2022-02-14 — Application abandoned
2022-02-14 — Final status recorded
Owner Information
Xellia Pharmaceuticals ApS
Xellia Pharmaceuticals ApS
Correspondent
Nicole K. McLaughlin Duane Morris LLP
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
